ImmuneOncia Announces Biomarker Results from Phase 1 Clinical Trial of CD47 Antibody at ASCO
SEOUL, South Korea--(BUSINESS WIRE)--#2024ASCOAnnualMeeting--ImmuneOncia (CEO Heung Tae Kim) announced the results of its solid tumour…
2 years ago
Alex
Outsource Accelerator Calls for Outsourcing Impact Review 2024 Entries
MANILA, Philippines--(BUSINESS WIRE)--#CSR--Outsource Accelerator, the premier source of independent information, advisory, and advocacy for the…
2 years ago
Bionova Scientific, U.S. biologics CDMO of the Asahi Kasei Group, to establish a facility in Texas and launch plasmid DNA business
TOKYO & NEW YORK & DÃœSSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei Medical's U.S. subsidiary Bionova Scientific, a…
2 years ago
AKM Achieves Successful Proof of Concept for eFuse in High Voltage 800 V Automotive Applications
Door opener for compact, fast and reliable protection of e.g., on-board chargers or DC/DC converters…
2 years ago
Energy Vault Executes EPC and O&M Contract with ACEN Australia for 200 MW/400 MWh of Battery Energy Storage Deployments
ACEN Australia and Energy Vault to begin deployment of two battery energy storage systems (BESS),…
2 years ago
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class…
2 years ago
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
SAN DIEGO--(BUSINESS WIRE)--#WGS--Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge…
2 years ago
International Energy Forum Report Details EV Copper Hurdles
Generation Mining Hosting Fireside Chat with Report Co-Author TORONTO--(BUSINESS WIRE)--$genm #copper--Generation Mining Limited (TSX:GENM, OTCQB:…
2 years ago
Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
– Phase 2b Trial Demonstrated Statistically Significant and Clinically Meaningful Improvements Across Primary and all…
2 years ago
Shining Bright atop Taipei 101, GIGABYTE Redefines AI Evolution Accelerated by Next-Generation Computing at COMPUTEX
TAIPEI--(BUSINESS WIRE)--#ACCEVOLUTION--Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products…
2 years ago